Cardiovascular outcomes trials have shown reduced rates of major adverse cardiac events
This is a question worth asking, because addiction treatment has a graveyard of promising approaches that never scaled
Furthermore, we detected severe outcomes in 46 cases of pancreatic carcinoma and all cases of pancreatic carcinoma metastatic ( n = 12), including 7 and 3 deaths, respectively, consistent with a clinical trial that reported 1 pancreatic carcinoma death, which was assessed as being probably related to semaglutide ( In addition to pancreatitis, among the moderate clinical priority signals, the most commonly reported semaglutide-related AEs were nausea (score 6), vomiting (score 6), diarrhea (score 5), constipation (score 6), and abdominal pain (score 5), and so on, which were consistent with the drug label
Semaglutide and tirzepatide are different medications with separate prescriptions
It is dose-dependent, reversible, and generally does not impair absorption of most co-administered medications to a clinically meaningful degree" (Mayo Clinic Proceedings, 2024)